Clinical trial
A Prospective, Multicenter Study to Investigate the Pharmacokinetics, Safety, and Efficacy of Cadazolid Versus Vancomycin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea
NCT03105479 is registered in ClinicalTrials.gov with Actelion as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter Study to Investigate the Pharmacokinetics, Safety, and Efficacy of Cadazolid Versus Vancomycin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea
- Lead sponsor
- Actelion
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- April 14, 2017
- Completion date
- April 17, 2018
- Enrollment
- 1 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.
clostridium difficile infection